Torthaí cuardaigh - Ilaria Iacobucci
- 1 - 20 toradh as 73 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Genetic Basis of Acute Lymphoblastic Leukemia de réir Ilaria Iacobucci, Charles G. Mullighan
Foilsithe / Cruthaithe 2017Revisão -
2
Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia de réir Ilaria Iacobucci, Shunsuke Kimura, Charles G. Mullighan
Foilsithe / Cruthaithe 2021Revisão -
3
Protein–DNA/RNA Interactions: An Overview of Investigation Methods in the -Omics Era de réir Flora Cozzolino, Ilaria Iacobucci, Vittoria Monaco, Maria Monti
Foilsithe / Cruthaithe 2021Revisão -
4
The cell cycle checkpoint inhibitors in the treatment of leukemias de réir Andrea Ghelli Luserna di Rorà, Ilaria Iacobucci, Giovanni Martinelli
Foilsithe / Cruthaithe 2017Revisão -
5
-
6
Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems de réir Daniele Florio, Anna Maria Malfitano, Sarah Di Somma, Carolin Mügge, Wolfgang Weigand, Giarita Ferraro, Ilaria Iacobucci, Maria Monti, Giancarlo Morelli, Antonello Merlino, Daniela Marasco
Foilsithe / Cruthaithe 2019Artigo -
7
Glucosyl Platinum(II) Complexes Inhibit Aggregation of the C-Terminal Region of the Aβ Peptide de réir Sara La Manna, Marilisa Leone, Ilaria Iacobucci, Alfonso Annuziata, Concetta Di Natale, Elena Lagreca, Anna Maria Malfitano, Francesco Ruffo, Antonello Merlino, Maria Monti, Daniela Marasco
Foilsithe / Cruthaithe 2022Artigo -
8
Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia de réir Giovanni Cazzaniga, Frederik W. van Delft, Luca Lo Nigro, Anthony M. Ford, Joannah Score, Ilaria Iacobucci, Elena Mirabile, Mary Taj, Susan Colman, Andrea Biondi, Mel Greaves
Foilsithe / Cruthaithe 2011Artigo -
9
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma de réir Enrico Derenzini, Claudio Agostinelli, Enrica Imbrogno, Ilaria Iacobucci, Beatrice Casadei, Elisa Brighenti, Simona Righi, Fabio Fuligni, Andrea Ghelli Luserna di Rorà, Anna Ferrari, Giovanni Martinelli, Stefano Pileri, Pier Luigi Zinzani
Foilsithe / Cruthaithe 2015Artigo -
10
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia de réir Andrea Ghelli Luserna di Rorà, Ilaria Iacobucci, Enrica Imbrogno, Cristina Papayannidis, Enrico Derenzini, Anna Ferrari, Viviana Guadagnuolo, Valentina Robustelli, Sarah Parisi, Chiara Sartor, Maria Chiara Abbenante, Stefania Paolini, Giovanni Martinelli
Foilsithe / Cruthaithe 2016Artigo -
11
Osteopontin binds ICOSL promoting tumor metastasis de réir Davide Raineri, Chiara Dianzani, Giuseppe Cappellano, Federica Maione, Gianluca Baldanzi, Ilaria Iacobucci, Nausicaa Clemente, Giulia Baldone, Elena Boggio, Casimiro Luca Gigliotti, Renzo Boldorini, José María Rojo, Maria Monti, Leila Birolo, Umberto Dianzani, Annalisa Chiocchetti
Foilsithe / Cruthaithe 2020Artigo -
12
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications de réir Cecilia Grimaldi, Francesca Chiarini, Giovanna Tabellini, Francesca Ricci, Pier Luigi Tazzari, Michela Battistelli, Elisabetta Falcieri, Roberta Bortul, Fraia Melchionda, Ilaria Iacobucci, P Pagliaro, Giovanni Martinelli, Andrea Pession, João T. Barata, James A. McCubrey, Alberto M. Martelli
Foilsithe / Cruthaithe 2011Artigo -
13
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia de réir Francesca Chiarini, Annalisa Lonetti, Gabriella Teti, Ester Orsini, Daniela Bressanin, Alessandra Cappellini, Francesca Ricci, Pier Luigi Tazzari, Andrea Ognibene, Mirella Falconi, Pasqualepaolo Pagliaro, Ilaria Iacobucci, Giovanni Martinelli, Sergio Amadori, James A. McCubrey, Alberto M. Martelli
Foilsithe / Cruthaithe 2012Artigo -
14
Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML de réir Andy G.X. Zeng, Ilaria Iacobucci, Sayyam Shah, Amanda Mitchell, Gordon Wong, Suraj Bansal, David Y. Chen, Qingsong Gao, Hyerin Kim, Theodore A. Kennedy, Andrea Arruda, Mark D. Minden, T. Haferlach, Charles G. Mullighan, John E. Dick
Foilsithe / Cruthaithe 2023Pré-impressão -
15
Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party de réir G. Rosti, Ilaria Iacobucci, Simona Bassi, Fausto Castagnetti, Marilina Amabile, Daniela Cilloni, Antonio Poerio, Simona Soverini, Francesca Palandri, Giovanna Rege Cambrin, F. Iuliano, Giuliana Alimena, Roberto Latagliata, Nicoletta Testoni, F. Pane, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli
Foilsithe / Cruthaithe 2007Artigo -
16
Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes de réir Carla Filì, Michele Malagola, Matilde Y. Follo, Carlo Finelli, Ilaria Iacobucci, Giovanni Martinelli, Federica Cattina, Cristina Clissa, Anna Candoni, Renato Fanin, Marco Gobbi, Monica Bocchia, Marzia Defina, Pierangelo Spedini, Cristina Skert, Lucia Manzoli, Lucio Cocco, Domenico Russo
Foilsithe / Cruthaithe 2013Artigo -
17
The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia de réir Yunchao Chang, Fatemeh Keramatnia, Pankaj S. Ghate, Gisele Nishiguchi, Qingsong Gao, Ilaria Iacobucci, Lei Yang, Divyabharathi Chepyala, Ashutosh Mishra, Anthony A. High, Hiroaki Goto, Koshi Akahane, Junmin Peng, Jun J. Yang, Marcus Fischer, Zoran Ranković, Charles G. Mullighan
Foilsithe / Cruthaithe 2023Artigo -
18
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis de réir Simona Soverini, Alessandro Vitale, Antonio Poerio, Alessandra Gnani, Sabrina Colarossi, Ilaria Iacobucci, G. Cimino, L Elia, Annalisa Lonetti, Marco Vignetti, Stefania Paolini, Giovanna Meloni, V. di Maio, Cristina Papayannidis, Marilina Amabile, Anna Guarini, Michele Baccarani, Giovanni Martinelli, R. Foà
Foilsithe / Cruthaithe 2010Artigo -
19
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party de réir Fausto Castagnetti, Francesca Palandri, Marilina Amabile, Nicoletta Testoni, Simona Luatti, Simona Soverini, Ilaria Iacobucci, Massimo Breccia, Giovanna Rege Cambrin, Fabio Stagno, Giorgina Specchia, Piero Galieni, F. Iuliano, Fabrizio Pane, Giuseppe Saglio, Giuliana Alimena, Giovanni Martinelli, Michele Baccarani, Gianantonio Rosti
Foilsithe / Cruthaithe 2009Artigo -
20
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression de réir Thorsten Klampfl, Ashot S. Harutyunyan, Tiina Berg, Bettina Gisslinger, Martin Schalling, Klaudia Bagienski, Damla Olcaydu, Francesco Passamonti, Elisa Rumi, Daniela Pietra, Roland Jäger, Lisa Pieri, Paola Guglielmelli, Ilaria Iacobucci, Giovanni Martinelli, Mario Cazzola, Alessandro M. Vannucchi, Heinz Gisslinger, Róbert Královics
Foilsithe / Cruthaithe 2011Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Cancer research
Genetics
Gene
Medicine
Leukemia
Internal medicine
Myeloid leukemia
Oncology
Immunology
Lymphoblastic Leukemia
Imatinib
Biochemistry
Imatinib mesylate
Cell biology
Cancer
Chemistry
Computational biology
Receptor
Tyrosine kinase
Chromosomal translocation
Philadelphia chromosome
Disease
Myeloid
Signal transduction
Dasatinib
Gene expression
Mutation
Stem cell
ABL